International Conference on Safety of Medicines & 21st Annual Conference of Society of Pharmacovigilance India
Abstract
In the ever-evolving landscape of healthcare, where the tapestry of medications expands with each passing year, ensuring the safety of these interventions remains paramount. This fundamental principle forms the bedrock of pharmacovigilance, a multifaceted discipline dedicated to the detection, assessment, understanding, and prevention of adverse effects associated with pharmaceutical products. With the growing prominence of modern medicines alongside the resurgence of alternative therapies, the field of pharmacovigilance faces an ever-increasing challenge: safeguarding patient well-being in the face of diverse pharmacological landscapes.
References
1. WHO. Regulation and prequalification. What is Pharmacovigilance?
(2023) Available at: https://www.who.int/teams/regulationprequalification/
regulation-and-safety/pharmacovigilance.
2. Kalaiselvan V, Srivastava S, Singh A, Gupta SK. Pharmacovigilance
in India: Present Scenario and Future Challenges. Drug Saf. 2019
Mar;42(3):339-346. doi: 10.1007/s40264-018-0730-7. PMID:
30269244.
3. Ghosh NS, Gupta SP and Rahman SZ. SoPI Supported National
Pharmacovigilance Conferences – A Report, J Pharmacovigilance
Drug Safety 2019; 16(1): 16-21 (ISSN: 0972-8899).
4. F.A. Khan, I.A. Khan. Society of Pharmacovigilance, India (2024).
Pg. 10-11 [From the official souvenir of the International Conference
on Safety of Medicines & 21st Annual Conference of Society of
Pharmacovigilance India (SoPICON 2024)].
5. Aligarh Muslim University. Department of Pharmacology (Updated
2024). Available at:
https://www.amu.ac.in/department/pharmacology.
6. SZ Rahman and A Rana. 14th Annual Conference of Society of
Pharmacovigilance, India – A Report. J Pharmacovig Drug Safety
2015; 12 (1): 52-54 (ISSN: 0972-8899)
7. Yadav R, Rahman SZ. Pharmacovigilance: Opportunity and Future
Career Prospects for Fresh Graduates – A Report. J Pharmacovig
Drug Safety 2021; 18 (1): 10-11
8. Society of Pharmacovigilance (India). Home (updated in 2024).
Available at: https://sopi.net.in/sopi-orations.html.
(2023) Available at: https://www.who.int/teams/regulationprequalification/
regulation-and-safety/pharmacovigilance.
2. Kalaiselvan V, Srivastava S, Singh A, Gupta SK. Pharmacovigilance
in India: Present Scenario and Future Challenges. Drug Saf. 2019
Mar;42(3):339-346. doi: 10.1007/s40264-018-0730-7. PMID:
30269244.
3. Ghosh NS, Gupta SP and Rahman SZ. SoPI Supported National
Pharmacovigilance Conferences – A Report, J Pharmacovigilance
Drug Safety 2019; 16(1): 16-21 (ISSN: 0972-8899).
4. F.A. Khan, I.A. Khan. Society of Pharmacovigilance, India (2024).
Pg. 10-11 [From the official souvenir of the International Conference
on Safety of Medicines & 21st Annual Conference of Society of
Pharmacovigilance India (SoPICON 2024)].
5. Aligarh Muslim University. Department of Pharmacology (Updated
2024). Available at:
https://www.amu.ac.in/department/pharmacology.
6. SZ Rahman and A Rana. 14th Annual Conference of Society of
Pharmacovigilance, India – A Report. J Pharmacovig Drug Safety
2015; 12 (1): 52-54 (ISSN: 0972-8899)
7. Yadav R, Rahman SZ. Pharmacovigilance: Opportunity and Future
Career Prospects for Fresh Graduates – A Report. J Pharmacovig
Drug Safety 2021; 18 (1): 10-11
8. Society of Pharmacovigilance (India). Home (updated in 2024).
Available at: https://sopi.net.in/sopi-orations.html.
